Search research articles
Contact Us
Filters
Showing results (81-90 of 90) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 90 results.
Immunohorizons
|
November 13, 2018
Targeting of Liver Mannan-Binding Lectin-Associated Serine Protease-3 with RNA Interference Ameliorates Disease in a Mouse Model of Rheumatoid Arthritis
Nirmal K Banda, Dhruv Desai, Robert I Scheinman, et al.
Allergy
|
March 20, 2019
Management of ocular allergy
Andrea Leonardi, Diana Silva, Daniel Perez Formigo, et al.
Frontiers in Oncology
|
June 3, 2025
Focal adhesion kinase promotes ribosome biogenesis to drive advanced thyroid cancer cell growth and survival
Meghan D Kellett, Vibha Sharma, Madeline E Sherlock, et al.
Allergy
|
July 28, 2021
Open-label follow-on study evaluating the efficacy, safety, and quality of life with extended daily oral immunotherapy in children with peanut allergy
Montserrat Fernandez-Rivas, Andrea Vereda, Brian P Vickery, et al.
Allergy
|
September 30, 2025
Drug-Induced Periocular and Ocular Surface Disorders: An EAACI Position Paper
Andrea Leonardi, Banu Bozkurt, Diana Silva, et al.
Molecular Cancer Research : MCR
|
February 9, 2019
Establishment and Characterization of Four Novel Thyroid Cancer Cell Lines and PDX Models Expressing the RET/PTC1 Rearrangement, BRAFV600E, or RASQ61R as Drivers
Rebecca E Schweppe, Nikita Pozdeyev, Laura A Pike, et al.
Endocrine-Related Cancer
|
January 27, 2018
Development of new preclinical models to advance adrenocortical carcinoma research
Katja Kiseljak-Vassiliades, Yu Zhang, Stacey M Bagby, et al.
The Lancet. Child & Adolescent Health
|
July 24, 2020
Efficacy and safety of oral immunotherapy with AR101 in European children with a peanut allergy (ARTEMIS): a multicentre, double-blind, randomised, placebo-controlled phase 3 trial
Jonathan O'B Hourihane, Kirsten Beyer, Allyah Abbas, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
December 28, 2020
Continuous and Daily Oral Immunotherapy for Peanut Allergy: Results from a 2-Year Open-Label Follow-On Study
Brian P Vickery, Andrea Vereda, Caroline Nilsson, et al.
The New England Journal of Medicine
|
November 20, 2018
AR101 Oral Immunotherapy for Peanut Allergy
, Brian P Vickery, Andrea Vereda, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 90) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 90 results.
Immunohorizons
|
November 13, 2018
Targeting of Liver Mannan-Binding Lectin-Associated Serine Protease-3 with RNA Interference Ameliorates Disease in a Mouse Model of Rheumatoid Arthritis
Nirmal K Banda, Dhruv Desai, Robert I Scheinman, et al.
Allergy
|
March 20, 2019
Management of ocular allergy
Andrea Leonardi, Diana Silva, Daniel Perez Formigo, et al.
Frontiers in Oncology
|
June 3, 2025
Focal adhesion kinase promotes ribosome biogenesis to drive advanced thyroid cancer cell growth and survival
Meghan D Kellett, Vibha Sharma, Madeline E Sherlock, et al.
Allergy
|
July 28, 2021
Open-label follow-on study evaluating the efficacy, safety, and quality of life with extended daily oral immunotherapy in children with peanut allergy
Montserrat Fernandez-Rivas, Andrea Vereda, Brian P Vickery, et al.
Allergy
|
September 30, 2025
Drug-Induced Periocular and Ocular Surface Disorders: An EAACI Position Paper
Andrea Leonardi, Banu Bozkurt, Diana Silva, et al.
Molecular Cancer Research : MCR
|
February 9, 2019
Establishment and Characterization of Four Novel Thyroid Cancer Cell Lines and PDX Models Expressing the RET/PTC1 Rearrangement, BRAFV600E, or RASQ61R as Drivers
Rebecca E Schweppe, Nikita Pozdeyev, Laura A Pike, et al.
Endocrine-Related Cancer
|
January 27, 2018
Development of new preclinical models to advance adrenocortical carcinoma research
Katja Kiseljak-Vassiliades, Yu Zhang, Stacey M Bagby, et al.
The Lancet. Child & Adolescent Health
|
July 24, 2020
Efficacy and safety of oral immunotherapy with AR101 in European children with a peanut allergy (ARTEMIS): a multicentre, double-blind, randomised, placebo-controlled phase 3 trial
Jonathan O'B Hourihane, Kirsten Beyer, Allyah Abbas, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
December 28, 2020
Continuous and Daily Oral Immunotherapy for Peanut Allergy: Results from a 2-Year Open-Label Follow-On Study
Brian P Vickery, Andrea Vereda, Caroline Nilsson, et al.
The New England Journal of Medicine
|
November 20, 2018
AR101 Oral Immunotherapy for Peanut Allergy
, Brian P Vickery, Andrea Vereda, et al.
Page
of 9